Today’s Stocks: RSP Permian, Inc. (NYSE:RSPP), Oncothyreon Inc (NASDAQ:ONTY), CBL & Associates Properties Inc. (NYSE:CBL), GlaxoSmithKline plc (NYSE:GSK), Imation Corp. (NYSE:IMN)

RSP Permian, Inc. (NYSE:RSPP) announced the commencement of an underwritten public offering of 6,000,000 shares of its common stock. The Company has granted the underwriter a 30-day option to purchase up to an additional 900,000 shares of the Company’s common stock.RSP Permian, Inc. (NYSE:RSPP) belongs to Basic Materials sector. Its net profit margin is 0.50% and weekly performance is -4.29%. On last trading day company shares ended up $22.76. RSP Permian, Inc. (NYSE:RSPP) distance from 50-day simple moving average (SMA50) is -16.51%.

Oncothyreon Inc (NASDAQ:ONTY) announced that it will conduct a conference call on Thursday, August 6, 2015 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its second quarter 2015 financial results. Oncothyreon Inc (NASDAQ:ONTY) shares decreased -0.27% in last trading session and ended the day at $3.63. ONTY return on assets is -46.40%. Oncothyreon Inc (NASDAQ:ONTY) quarterly performance is 155.63%.

CBL & Associates Properties Inc. (NYSE:CBL) announced that its Board of Directors has authorized a share repurchase program for the Company to buy up to $200 million of its common stock. The Company plans to repurchase shares from time to time on the open market, in privately negotiated transactions or otherwise, depending on market prices and other conditions. Purchases may be made through the program through August 31, 2016.On 04 August, CBL & Associates Properties Inc. (NYSE:CBL) shares decreased -1.54% and was closed at $16.03. CBL EPS growth in last 5 year was 7.20%. CBL & Associates Properties Inc. (NYSE:CBL) year to date (YTD) performance is -14.96%.

GlaxoSmithKline plc (NYSE:GSK)‘s stock had its “underperform” rating reissued by stock analysts at BNP Paribas in a report released on Monday. They currently have a $21.56 price target on the stock. BNP Paribas’ price objective would suggest a potential downside of 1.15% from the company’s previous close. GlaxoSmithKline plc (NYSE:GSK) ended the last trading day at $43.45. Company weekly volatility is calculated as 1.57% and price to cash ratio as 8.92. GlaxoSmithKline plc (NYSE:GSK) showed a weekly performance of 4.17%.

On 28 July, Imation Corp. (NYSE:IMN) announced that Imation Lock & Key – a new feature of Imation’s Nexsan Assureon™ secure archive solution that adds a critical layer of administrator security to data storage environments, protecting high-value data files from internal and external threats – is now generally available for sale. Imation has begun selling and shipping Lock & Key. Imation Corp. (NYSE:IMN) shares decreased -1.79% in last trading session and ended the day at $3.85. IMN Gross Margin is 19.60% and its return on assets is -22.00%. Imation Corp. (NYSE:IMN) quarterly performance is -6.10%.

Leave a Reply

Your email address will not be published. Required fields are marked *